ÂÜÀòÂÒÂ×

Andrew Green has extensive work experience in the pharmaceutical industry. Andrew is currently working at ICON plc as an Executive Principal, responsible for leading and overseeing various projects. Prior to this, they worked at 3G Consulting Ltd as a Co-Founder/Director. Andrew also served as a Global Market Access and Strategic Pricing Advisor at Alverium Health. Before that, they held multiple roles at GSK, including Head of Global Market Access and Pricing for the Respiratory Franchise. Andrew has also worked at Astellas Pharma as a Market Access Lead and had a career break as a Full-Time Dad. Andrew'searlier experience includes roles at Pfizer, where they held various positions focused on pricing, market access, and business development. Andrew started their career at Servier Laboratories as a Medical Representative.

Andrew Green holds an MBA in Business Studies from Hult Ashridge, which they obtained from 2005 to 2007. Andrew also has a B.Sc. (Hons) in Pharmacology from the University of Sunderland, which they completed from 1988 to 1991. In addition to their degrees, Andrew Green has acquired several certifications, including "Modelling Cost-Effectiveness in Healthcare" and "Certificate in Health Economics and Policy" from The London School of Economics and Political Science (LSE), obtained in 2022 and 2021 respectively. Andrew also earned a certification in "Developing a successful biopharmaceutical pricing and market access strategy" from the University of Cambridge in 2021.